Mobile cancer screening devices market to reach $9.05B by 2030

The mobile cancer screening devices market is projected to grow from $4.88 billion in 2025 to $5.54 billion in 2026, driven by rising cancer cases, early detection programs and broader access to care. The Business Research Company says North America led the market in 2025, while Asia-Pacific is set for the fastest growth through 2030.

Why it matters: - Mobile cancer screening devices extend cancer testing beyond hospitals and labs. - The market is expanding as health systems push earlier diagnosis and broader screening access in rural and underserved areas. - The category is becoming more important as cancer incidence rises globally and healthcare providers look for portable diagnostic options.

What happened: - The Business Research Company published a market report on mobile cancer screening devices on Sept. 9, 2026. - The report projects market value will rise from $4.88 billion in 2025 to $5.54 billion in 2026. - The report forecasts the market will reach $9.05 billion by 2030. - The projected growth rate is 13.5% from 2025 to 2026 and 13.1% from 2026 to 2030. - The report frames mobile cancer screening devices as portable medical tools used to detect early cancer signs outside traditional clinical settings. - A free sample of the report is available. - The full report is also available.

The details: - The report says growth is being driven by rising global cancer rates, government awareness efforts, demand for early detection, expanded access in underserved areas and higher healthcare infrastructure spending. - The report also points to growing investment in portable diagnostic technology, AI-based screening platforms, decentralized care delivery, preventive health programs and molecular diagnostics. - Mobile cancer screening devices are designed for on-site screening in remote, rural and underserved regions. - The CDC reported in January 2026 that the U.S. recorded 1,851,238 new cancer cases in 2022 and 613,349 cancer deaths in 2023. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will post the fastest growth over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The report suggests the market is shifting from a niche portable-device category to a core part of decentralized cancer care. - AI and molecular diagnostics may become key differentiators as providers look for faster and more accurate screening tools. - Regional growth patterns point to mature demand in North America and faster adoption in markets still expanding healthcare access.

What's next: - The report expects continued gains through 2030 as governments, providers and device makers invest in early detection infrastructure. - Wider use of AI screening platforms and portable diagnostics could accelerate deployment in community-based care settings. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards and trend graphics. - The company lists contact details for experts and invites readers to follow its social channels for updates.